aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.4800
-0.0030 (-0.62%)
At close: Jul 30, 2026, 4:00 PM EDT
0.4800
0.00 (0.00%)
After-hours: Jul 30, 2026, 5:40 PM EDT
aTyr Pharma Revenue
In the year 2025, aTyr Pharma had annual revenue of $190.00K, down -19.15%.
Revenue (ttm)
$190.00K
Revenue Growth
-19.15%
P/S Ratio
251.53
Revenue / Employee
$3,167
Employees
60
Market Cap
47.06M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 190.00K | -45.00K | -19.15% |
| Dec 31, 2024 | 235.00K | -118.00K | -33.43% |
| Dec 31, 2023 | 353.00K | -10.03M | -96.60% |
| Dec 31, 2022 | 10.39M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 10.46M | 10.03M | 2,377.49% |
| Dec 31, 2019 | 422.00K | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Metagenomi Therapeutics | 22.33M |
| TScan Therapeutics | 9.14M |
| Immutep | 5.28M |
| BeyondSpring | 1.88M |
| Seres Therapeutics | 1.15M |
| Mereo BioPharma Group | 500.00K |
| INmune Bio | 50.00K |
| Impact BioMedical | 39.00K |
ATYR News
- 9 days ago - Ethos and North American Expand Their Indexed Universal Life Product Offering to include Children - GlobeNewsWire
- 15 days ago - aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026 - GlobeNewsWire
- 4 weeks ago - Ethos to Announce Second Quarter 2026 Financial Results on August 3, 2026 - GlobeNewsWire
- 5 weeks ago - aTyr Pharma Transcript: Life Sciences Virtual Investor Forum - Transcripts
- 2 months ago - aTyr Pharma Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Forget the SpaceX IPO. These 2 New Stocks Stand Out Right Now. - Barrons
- 2 months ago - Ethos Partners with Baseball Legend David Ortiz to Champion Life Insurance as a Family Financial Essential - GlobeNewsWire
- 2 months ago - aTyr Pharma upgraded to Buy from Hold at Freedom Broker - TheFly